Showcasing the strength of the Canadian life sciences industry at the OBIO® Investment Summit
Global investors and strategic pharma teams met with over 100 of Canada’s most investable life sciences and health tech companies and our top research institutions at the OBIO® Investment Summit (OIS) from February 5 -7, 2025. The eighth annual Summit was held in Toronto and showcased Canada’s early-stage entrepreneurs seeking Pre-Seed, Seed and Series A funding. The audience comprised nearly 200 investors representing over 100 unique venture capitalists, corporate ventures and Angel investor groups; a quarter of the investors were based outside of Canada. The OBIO® Investment Summit is Canada’s Premier Health Science Investment Event and companies that have presented at the Summit have raised over CAD $1.6 billion since 2018.
The three-day Summit would not be possible without the support that we have received from our sponsors and partners.